1,8-Diazabicyclo(5.4.0)undec-7-ene → 5,7-dimethyl-2-(2-(3-(pyrrolidin-1-yl)-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)vinyl)-[1,2,4]triazolo[1,5-a]pyrimidine

HRID 1054957Notes

Reaction equation

HRID 1054957 reaction equation
[N:1]1([C:6]2[N:10]=[C:9]([CH:11]=O)[N:8]([CH2:13][C:14]([F:17])([F:16])[F:15])[N:7]=2)[CH2:5][CH2:4][CH2:3][CH2:2]1.[Cl-].[CH3:19][C:20]1[CH:25]=[C:24]([CH3:26])[N:23]2[N:27]=[C:28]([CH2:30][P+](C3C=CC=CC=3)(C3C=CC=CC=3)C3C=CC=CC=3)[N:29]=[C:22]2[N:21]=1.N1CCCN2CCCCCC=12>O1CCCC1>[CH3:19][C:20]1[CH:25]=[C:24]([CH3:26])[N:23]2[N:27]=[C:28]([CH:30]=[CH:11][C:9]3[N:8]([CH2:13][C:14]([F:17])([F:16])[F:15])[N:7]=[C:6]([N:1]4[CH2:5][CH2:4][CH2:3][CH2:2]4)[N:10]=3)[N:29]=[C:22]2[N:21]=1

Participants

5

Conditions

Temperature
25 °C

Procedure

A mixture of 3-(pyrrolidin-1-yl)-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazole-5-carbaldehyde (54 mg, 218 μmol, Eq: 1.00), ((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)triphenylphosphonium chloride (99.8 mg, 218 μmol, Eq: 1.00) and 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine (82.8 mg, 544 μmol, Eq: 2.5) in tetrahydrofuran (3.36 ml) was stirred for 18 hours at 25° C. under argon atmosphere. Chromatography afforded 5,7-dimethyl-2-{2-[5-pyrrolidin-1-yl-2-(2,2,2-trifluoro-ethyl)-2H-[1,2,4]triazol-3-yl]-vinyl}-[1,2,4]triazolo[1,5-a]pyrimidine (20 mg/23.4%) as a light yellow viscous oil. MS: m/z=393.4 (M+H+).

Sources & evidence

ORD record
ord-fc9947349f164797b31d65f491e95425
Source dataset
uspto-grants-2016_07
Patent number
US09394311B2

Reaction notes

Loading…